The Latest Breaking News from Haleon

Pharmaceutical stocks GSK, Sanofi and Haleon extended deep losses Thursday amid looming litigation around recalled heartburn drug Zantac.

Consumer goods spin-off makes few waves in biggest European listing for more than a decade

Consumer healthcare business Haleon makes its debut on the London stock market today after completing its demerger from GSK.

Close on the heels of an M&A deal, GlaxoSmithKline plc (NYSE: GSK) confirmed the spin-off of the consumer healthcare business it jointly owns with U.S. pharma giant Pfizer, Inc.

Reuters Redbird Capital Buys Italian Football Club AC Milan

Pfizer Inc. (NYSE:PFE) intends to sell its 32% investment in Haleon, a consumer health joint venture with GSK plc (NYSE:GSK), after the business is spun out as an independent listed company in July, reported Reuters. Pfizer had previously indicated that it might seek to sell its stake in Haleon, a consumer health company and…

Oil is always a political business, and there’s no point pretending otherwise

Expected to be the biggest London listing in a decade, the Haleon demerger is scheduled for July

Products such as Voltaren, Sensodyne and Panadol to regroup under new stock market listing in summer